MedPath

A Comparison of Pain Severity on Injection of MCT/LCT Propofol Between Lidocaine 20 mg, 40 mg, and Without Lidocaine.

Not Applicable
Completed
Conditions
Adult Disease
Interventions
Registration Number
NCT01345981
Lead Sponsor
Prince of Songkla University
Brief Summary

To compare the severity of pain on injection of MCT/LCT propofol with lidocaine 20 mg, 40 mg, and without lidocaine.

Detailed Description

Background: Intravenous injection of propofol produces pain. Many factors are involved and various techniques have been tried to minimize the propofol-induce pain with variable results.

Objective: To compare the severity of pain on injection of MCT/LCT propofol with lidocaine 20 mg, 40 mg, and without lidocaine.

Design: Randomize controlled trial. Method: Two hundred and ten ASA class I - III patients undergoing elective surgery were blinded and equally allocated into 3 groups. Patients in group N, L1, and L2 received MCT/LCT propofol 10 ml mixed with 0.9% NaCl 2 ml, 1% lidocaine 2 ml, and 2% lidocaine 2 ml respectively. Pain at time of propofol injection was assessed by blinded anesthesiologist on a four point scale ; 0 = no pain, 1 = mild pain, 2 = moderate pain, and 3 = severe pain. Results: Patient's demographic data of each group were similar. There were significant differences in the incidence of propofol injection without pain among groups (p\<0.001). The numbers of patients who had moderate and severe pain in groups L1 and L2 were significantly less than those in group N (p\<0.001). The mean blood pressure and heart rate were not significant differences in among groups. Conclusion : The amount of 20 mg, and 40 mg lidocaine to MCT/LCT propofol in our study is equally effective in decreasing pain and more effective than MCT/LCT propofol alone group significantly. They were no significant differences in hemodynamics change in among groups.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
210
Inclusion Criteria
  • ASA class I - III patients
  • undergoing elective surgery
  • age 18-75 years
Exclusion Criteria
  • allergy to propofol and lidocaine
  • abnormal liver and renal functions
  • has psychological problem or drug abuse
  • has recieved analgesic drug 2 weeks prior to surgery
  • risk of aspiration

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
normal salineLidocaine2 ml
lidocaine 20 mgLidocaineintravenous lidocaine
lidocaine 40 mgLidocaineintravenous lidocaine 40 mg
Primary Outcome Measures
NameTimeMethod
pain on injection30 minutes

4 points score for pain:o=no pain,1=mild pain,2=moderate pain,3=severe pain after propofol injection

Secondary Outcome Measures
NameTimeMethod
hemodynamic change30 minutes

blood pressure and heart rate after propofol injection

Trial Locations

Locations (1)

Songklanagarind Hospital

🇹🇭

Hatyai, Songkhla, Thailand

© Copyright 2025. All Rights Reserved by MedPath